ScreenerHero

NVSNovartis AG

NYSE · US · Healthcare · Drug Manufacturers - General · novartis.com
158.86USDMkt Cap: 301.95B $P/E: 24.00

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.12TUSDP/E 42.2
JNJ
Johnson & Johnson
$651.25BUSDP/E 31.4
ABBV
AbbVie Inc.
$468.22BUSDP/E 75.1
RO
Roche Holding AG
$345.19BUSDP/E 24.7
MRK
Merck & Co., Inc.
$376.37BUSDP/E 122.0
NOVNEE
Novartis AG
$283.47BUSDP/E 22.7
NOVN
Novartis AG
$276.41BUSDP/E 23.7
AZN
AstraZeneca PLC
$234.02BUSDP/E 25.0
AZN
AstraZeneca PLC
$257.42BUSDP/E 24.8
AZN
AstraZeneca PLC
$240.45BUSDP/E 24.5
AMGN
Amgen Inc.
$237.11BUSDP/E 27.0
NVO
Novo Nordisk A/S
$206.69BUSDP/E 11.5
GILD
Gilead Sciences, Inc.
$181.18BUSD
PFE
Pfizer, Inc.
$159.99BUSDP/E 36.9
BMY
Bristol-Myers Squibb Company
$136.88BUSDP/E 14.8
SAN
Sanofi
$102.80BUSDP/E 24.4
SNY
Sanofi
$109.86BUSDP/E 24.1
GSK
GSK plc
$98.67BUSDP/E 16.3
GSK
GSK plc
$104.97BUSDP/E 16.4
BAYN
Bayer Aktiengesellschaft
$51.30BUSD

Key Statistics

Company
Market Cap301.95B $
Enterprise Value343.75B $
Revenue (TTM)56.69B $
Gross Profit42.98B $
Net Income (TTM)13.98B $
Revenue/Share29.64 USD
Last Price158.86 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)24.00
P/E (Forward)16.20
PEG3.63
EV/EBITDA14.88
EV/Revenue6.06
P/S5.33
P/B7.27
EPS (TTM)6.62
EPS (Forward)9.81
52W Range
156.1176% of range159.71
52W High159.71 USD
52W Low156.11 USD
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF19.14B $
CapEx (TTM)3.90B $
FCF Margin20.99%
FCF Yield3.94%
Net Debt41.40B $
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh21.86 USD
Cash/Share4.008 USD
Dividends
Fwd Div Rate4.740 USD
Trail. Div Rate4.666 USD
Div. Yield2.98%
5Y Avg Yield3.51%
Payout Ratio71.60%
Ex-Div DateMar 11, 2026
Pay DateMar 16, 2026
Splits
Last Split1116:1000
Split DateApr 9, 2019
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)157.15 USD
Upside (mean)-1.1%
Target Range123.00 USD – 180.00 USD
$123.00-1.1% to mean$180.00
# Analysts11
Ownership
Shares Out.1.90B
Float1.86B
Insiders0.01%
Institutions7.27%
Short Interest
Short Ratio2.9d
Short % Float0.28%
Short % Out.0.28%
Shares Short5.24M
Short (prev mo.)5.36M
Technical
SMA 50154.33 (+2.9%)
SMA 200148.25 (+7.2%)
Beta0.49
S&P 52W Chg19.18%
Avg Vol (30d)1.08M
Avg Vol (10d)1.54M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—